Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
2.2100
+0.0600 (2.79%)
Salarius Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for cancer patients
The company specializes in the research and development of novel drug candidates that target specific epigenetic mechanisms to combat various forms of cancer. By harnessing the potential of these targeted therapies, Salarius aims to improve treatment outcomes and minimize side effects for patients. The company's approach emphasizes precision medicine, with a commitment to addressing unmet medical needs in oncology through robust scientific innovation and clinical trials.
Frequently Asked Questions
Is Salarius Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Salarius Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Salarius Pharmaceuticals, Inc. - Common Stock trade on?
Salarius Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Salarius Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Salarius Pharmaceuticals, Inc. - Common Stock is SLRX on the Nasdaq Stock Market
What is the current price of Salarius Pharmaceuticals, Inc. - Common Stock?
The current price of Salarius Pharmaceuticals, Inc. - Common Stock is 2.210
When was Salarius Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Salarius Pharmaceuticals, Inc. - Common Stock was at 9:30 am EST on January 31st, 2025
What is the market capitalization of Salarius Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Salarius Pharmaceuticals, Inc. - Common Stock is 98.96M
How many shares of Salarius Pharmaceuticals, Inc. - Common Stock are outstanding?
Salarius Pharmaceuticals, Inc. - Common Stock has 44.78M shares outstanding.